|
Volumn 73, Issue 12, 1994, Pages 3081-3086
|
A randomized clinical trial of single‐dose versus fractionated‐dose dactinomycin in the treatment of wilms' tumor. Results after extended follow‐up
|
Author keywords
chemotherapy; kidney cancer; pediatric cancer; survival; Wilms' tumor
|
Indexed keywords
DACTINOMYCIN;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER REGRESSION;
CANCER STAGING;
CANCER SURVIVAL;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
FEMALE;
HUMAN;
INFANT;
LENGTH OF STAY;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
MALE;
NEPHROBLASTOMA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
CHILD, PRESCHOOL;
DACTINOMYCIN;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INFANT;
KIDNEY NEOPLASMS;
MALE;
SURVIVAL RATE;
WILMS TUMOR;
|
EID: 0028359322
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/1097-0142(19940615)73:12<3081::AID-CNCR2820731229>3.0.CO;2-1 Document Type: Article |
Times cited : (25)
|
References (17)
|